Cargando…

Accelerated brain aging in major depressive disorder and antidepressant treatment response: A CAN-BIND report

OBJECTIVES: Previous studies suggest that major depressive disorder (MDD) may be associated with volumetric indications of accelerated brain aging. This study investigated neuroanatomical signs of accelerated aging in MDD and evaluated whether a brain age gap is associated with antidepressant respon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ballester, Pedro L., Suh, Jee Su, Nogovitsyn, Nikita, Hassel, Stefanie, Strother, Stephen C., Arnott, Stephen R., Minuzzi, Luciano, Sassi, Roberto B., Lam, Raymond W., Milev, Roumen, Müller, Daniel J., Taylor, Valerie H., Kennedy, Sidney H., Frey, Benicio N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556529/ https://www.ncbi.nlm.nih.gov/pubmed/34710675 http://dx.doi.org/10.1016/j.nicl.2021.102864

Ejemplares similares

A detailed manual segmentation procedure for the hypothalamus for 3T T1-weighted MRI
por: Ali, Mohammad, et al.
Publicado: (2022)

An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report
por: Suh, Jee Su, et al.
Publicado: (2020)

Gray matter volume drives the brain age gap in schizophrenia: a SHAP study
por: Ballester, Pedro L., et al.
Publicado: (2023)

Exploring brain connectivity changes in major depressive disorder using functional‐structural data fusion: A CAN‐BIND‐1 study
por: Ayyash, Sondos, et al.
Publicado: (2021)

Association between the expression of lncRNA BASP-AS1 and volume of right hippocampal tail moderated by episode duration in major depressive disorder: a CAN-BIND 1 report
por: Yrondi, Antoine, et al.
Publicado: (2021)

Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report
por: Harris, Jacqueline K., et al.
Publicado: (2022)

Reliability of a functional magnetic resonance imaging task of emotional conflict in healthy participants
por: Hassel, Stefanie, et al.
Publicado: (2019)

Multisite Comparison of MRI Defacing Software Across Multiple Cohorts
por: Theyers, Athena E., et al.
Publicado: (2021)

Magnetic Resonance Imaging Sequence Identification Using a Metadata Learning Approach
por: Liang, Shuai, et al.
Publicado: (2021)

Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 report
por: Caspani, Giorgia, et al.
Publicado: (2021)

Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report
por: Sajjadian, Mehri, et al.
Publicado: (2023)

Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant Medication
por: Schwartzmann, Benjamin, et al.
Publicado: (2023)

Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1
por: Nunez, John-Jose, et al.
Publicado: (2021)

The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report
por: Harkness, Kate L., et al.
Publicado: (2023)

Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study
por: Islam, Farhana, et al.
Publicado: (2022)

Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response
por: Fiori, Laura M., et al.
Publicado: (2021)

Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort
por: Lam, Raymond W., et al.
Publicado: (2016)

Association Between Side Effects and Blood microRNA Expression Levels and Their Targeted Pathways in Patients With Major Depressive Disorder Treated by a Selective Serotonin Reuptake Inhibitor, Escitalopram: A CAN-BIND-1 Report
por: Yrondi, Antoine, et al.
Publicado: (2019)

Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response
por: Marshe, Victoria S., et al.
Publicado: (2021)

Biological rhythms are independently associated with quality of life in bipolar disorder
por: Cudney, Lauren E., et al.
Publicado: (2016)

Comorbid Premenstrual Dysphoric Disorder and Bipolar Disorder: A Review
por: Slyepchenko, Anastasiya, et al.
Publicado: (2021)

Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants
por: Ju, Chelsey, et al.
Publicado: (2019)

SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants
por: Lin, Rixing, et al.
Publicado: (2023)

A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study
por: Slyepchenko, Anastasiya, et al.
Publicado: (2023)

Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy
por: Espinola, Caroline W., et al.
Publicado: (2022)

From anatomy to function: the role of the somatosensory cortex in emotional regulation
por: Kropf, Erika, et al.
Publicado: (2018)

The Use of Cannabinoids for Insomnia in Daily Life: Naturalistic Study
por: Kuhathasan, Nirushi, et al.
Publicado: (2021)

An investigation of cannabis use for insomnia in depression and anxiety in a naturalistic sample
por: Kuhathasan, Nirushi, et al.
Publicado: (2022)

“One Degree of Separation”: A Mixed-Methods Evaluation of Canadian Mental Health Care User and Provider Experiences With Remote Care During COVID-19
por: Ceniti, Amanda K., et al.
Publicado: (2022)

Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study
por: Schwartzmann, Benjamin, et al.
Publicado: (2023)

Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression
por: Zhdanov, Andrey, et al.
Publicado: (2020)

Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression
por: Farzan, Faranak, et al.
Publicado: (2017)

Rasch analyses of the Quick Inventory of Depressive Symptomatology Self-Report in neurodegenerative and major depressive disorders
por: Vaccarino, Anthony L., et al.
Publicado: (2023)

MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes
por: Lopez, Juan Pablo, et al.
Publicado: (2017)

Volumetric MRI Analysis of a Case of Severe Ventriculomegaly
por: Alders, Gésine L., et al.
Publicado: (2018)

OR25-4 Modulatory Effects of Estradiol on the Resting-State Functional Connectivity in Transwomen Following Gender Affirming Surgery
por: Schneider, Maiko, et al.
Publicado: (2019)

A DSM-5-based tool to monitor concurrent mood and premenstrual symptoms: the McMaster Premenstrual and Mood Symptom Scale (MAC-PMSS)
por: Frey, Benicio N., et al.
Publicado: (2022)

Response of Depression to Botulinum Toxin Treatment: Agitation as a Predictor
por: Milev, Roumen
Publicado: (2015)

Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder
por: Behr, Guilherme A., et al.
Publicado: (2012)

A Review of Antidepressant Therapy in Primary Care: Current Practices and Future Directions
por: Kennedy, Sidney H.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fc1bf58l28bqih7jgbg2kg3bhl